ArticleNature communications2026
A cryptic symmetry switch allosterically controls how the PF4 self-protein turns into a pathogenic antigen.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The asymmetry of dimers-of-dimers formed by Platelet Factor 4 (PF4) renders this endogenous protein immunogenic, triggering autoimmune responses such as heparin-induced thrombocytopenia (HIT). Yet, the molecular basis of PF4 asymmetry has remained elusive. Here, we show that cryptic conformational switches control PF4 tetramer asymmetry and explain how a benign self-protein morphs into an immunogenic antigen, triggering a pathogenic autoimmune response. Mutations that target symmetry-switching sites stabilize a symmetric PF4 tetramer with markedly reduced affinity for HIT antibodies. These findings overturn the long-standing hypothesis that electrostatics alone drive PF4 asymmetry. Furthermore, stabilization of symmetric tetramers provides a conceptual framework for the robust conformational stratification of HIT antibodies, a persistent diagnostic challenge. Overall, our integrative model addresses key questions about the determinants of PF4 tetramer asymmetry and epitope exposure, suggesting a generalizable strategy for attenuating autoimmune responses by selectively stabilizing non‑immunogenic conformational states of self‑proteins rather than globally suppressing immunity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.